Cargando…

Noncoding RNAs in gastric cancer: implications for drug resistance

Gastric cancer is the fourth most common malignancy and the third leading cause of cancer-related deaths worldwide. Advanced gastric cancer patients can notably benefit from chemotherapy including adriamycin, platinum drugs, 5-fluorouracil, vincristine, and paclitaxel as well as targeted therapy dru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Ling, Sun, Jujie, Zhang, Nasha, Zheng, Yan, Wang, Xingwu, Lv, Liyan, Liu, Jiandong, Xu, Yeyang, Shen, Yue, Yang, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081551/ https://www.ncbi.nlm.nih.gov/pubmed/32192494 http://dx.doi.org/10.1186/s12943-020-01185-7

Ejemplares similares

Noncoding RNAs: an emerging modulator of drug resistance in pancreatic cancer
por: Wei, Ling, et al.
Publicado: (2023)

The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma
por: Wei, Ling, et al.
Publicado: (2019)

Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer
por: Wei, Ling, et al.
Publicado: (2021)

MED13L integrates Mediator-regulated epigenetic control into lung cancer radiosensitivity
por: Zhang, Nasha, et al.
Publicado: (2020)

Long-noncoding RNAs (lncRNAs) in drug metabolism and disposition, implications in cancer chemo-resistance
por: Wang, Yue, et al.
Publicado: (2020)

Identification of Leukocyte telomere length-related genetic variants contributing to predisposition of Esophageal Squamous Cell Carcinoma
por: Li, Ziqiang, et al.
Publicado: (2020)

Noncoding RNAs in cancer therapy resistance and targeted drug development
por: Wang, Wen-Tao, et al.
Publicado: (2019)

Integrative Functional Genomics Implicated the Key T-/B-Cell Deficiency Regulator RAG1 in Transarterial Chemoembolization of Hepatocellular Carcinoma
por: Xu, Yeyang, et al.
Publicado: (2021)

Noncoding RNAs in Drug Resistance of Gastrointestinal Stromal Tumor
por: Li, Jiehan, et al.
Publicado: (2022)

miR-1262 suppresses gastric cardia adenocarcinoma via targeting oncogene ULK1
por: Zheng, Yan, et al.
Publicado: (2021)

Long Noncoding RNAs: New Regulators of Resistance to Systemic Therapies for Gastric Cancer
por: Sun, Weihong, et al.
Publicado: (2021)

Noncoding RNAs as sensors of tumor microenvironmental stress
por: Lv, Yue, et al.
Publicado: (2022)

Fractionated irradiation induced radio-resistant esophageal cancer EC109 cells seem to be more sensitive to chemotherapeutic drugs
por: Xie, Li, et al.
Publicado: (2009)

Recent Progress in Characterizing Long Noncoding RNAs in Cancer Drug Resistance
por: Zhao, Wenyuan, et al.
Publicado: (2019)

Autophagy Related Noncoding RNAs: Emerging Regulatory Factors of Gastric Cancer
por: Lu, Ling, et al.
Publicado: (2022)

Regulation of long noncoding RNAs in the pathogenesis and clinical implications of pituitary adenomas
por: Wang, Ling, et al.
Publicado: (2023)

Mechanisms of Action And Clinical Implications of MicroRNAs in the Drug Resistance of Gastric Cancer
por: Liu, Ying, et al.
Publicado: (2021)

Molecular mechanisms of long noncoding RNAs on gastric cancer
por: Li, Tianwen, et al.
Publicado: (2016)

Methylation and Noncoding RNAs in Gastric Cancer: Everything Is Connected
por: Bure, Irina V., et al.
Publicado: (2021)

Long Noncoding RNAs-Related Diseases, Cancers, and Drugs
por: Tang, Jen-Yang, et al.
Publicado: (2013)

Prognostic value of long noncoding RNAs in gastric cancer: a meta-analysis
por: Gao, Song, et al.
Publicado: (2018)

Noncoding RNAs as an emerging resistance mechanism to immunotherapies in cancer: basic evidence and therapeutic implications
por: Wang, Man, et al.
Publicado: (2023)

From Transcriptome to Noncoding RNAs: Implications in ALS Mechanism
por: Gagliardi, Stella, et al.
Publicado: (2012)

Potential Implications of Long Noncoding RNAs in Autoimmune Diseases
por: Hur, Keun, et al.
Publicado: (2019)

Noncoding RNA in drug resistant sarcoma
por: Li, Xiaoyang, et al.
Publicado: (2017)

Long noncoding RNAs in gastric cancer: From molecular dissection to clinical application
por: Gao, Yue, et al.
Publicado: (2020)

The role of exosomal noncoding RNAs in cancer
por: Xie, Yan, et al.
Publicado: (2019)

Long noncoding RNAs: glycolysis regulators in gynaecologic cancers
por: Lv, Nengyuan, et al.
Publicado: (2023)

Noncoding RNAs in pediatric brain tumors: Molecular functions and pathological implications
por: Chen, Shaohuai, et al.
Publicado: (2021)

Decoding Noncoding RNAs: Role of MicroRNAs and Long Noncoding RNAs in Ocular Neovascularization
por: Zhang, Yan, et al.
Publicado: (2017)

Long noncoding RNAs in gastric cancer: functions and clinical applications
por: Wang, Jiajun, et al.
Publicado: (2016)

Noncoding RNAs and hyperthermic intraperitoneal chemotherapy in advanced gastric cancer
por: Zeng, Lisi, et al.
Publicado: (2022)

Role of Noncoding RNAs in the Tumor Immune Microenvironment of Hepatocellular Carcinoma
por: Lv, Yue, et al.
Publicado: (2023)

Long Noncoding RNAs in the Pathogenesis of Insulin Resistance
por: Yang, Weili, et al.
Publicado: (2022)

Noncoding RNAs Involved in the Pathogenesis of Ankylosing Spondylitis
por: Chen, Chong, et al.
Publicado: (2019)

Noncoding RNAs
por: Hardikar, Anandwardhan A., et al.
Publicado: (2012)

The Regulation of Ferroptosis by Noncoding RNAs
por: Zheng, Xiangnan, et al.
Publicado: (2023)

Role of noncoding RNA in drug resistance of prostate cancer
por: Ding, Lifeng, et al.
Publicado: (2021)

Long noncoding RNAs in prostate cancer: overview and clinical implications
por: Malik, Bhavna, et al.
Publicado: (2016)

Noncoding RNAs implication in cardiovascular diseases in the COVID-19 era
por: Greco, S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i2lt759jpsf0o6en5fihdbtvd7